文献速递其他结缔组织病

系统性硬化症全球发病率与患病率:综合系统评价与荟萃分析

Incidence and prevalence of systemic sclerosis globally: a comprehensive systematic review and meta-analysis.
PubMed 文献 · Rheumatology (Oxford) · 2021-01-01

该研究系统检索MEDLINE、Web of Science和Embase,纳入61项患病率研究和39项发病率研究,采用随机效应模型合并估计。系统性硬化症总体合并患病率为每10万人17.6例(95%CI 15.1, 20.5),合并发病率为每10万人年1.4例(95%CI 1.1, 1.9)。研究报告存在显著地区异质性,北美研究估计值明显高于其他地区,女性发病率和患病率约为男性的五倍,较新研究报道的估计值高于较早研究。

要点

  • SSc总体合并患病率为17.6/10万(95%CI 15.1, 20.5)。
  • SSc总体合并发病率为1.4/10万人年(95%CI 1.1, 1.9)。
  • 女性发病率和患病率约为男性的五倍,北美估计值高于其他地区。

核心结论

  • 全球SSc发病率与患病率估计存在较大异质性,解读结果时需考虑此因素。

研究设计与样本

  • 遵循PRISMA 2009声明的系统评价与荟萃分析,检索MEDLINE、Web of Science和Embase,纳入61项患病率研究和39项发病率研究,采用随机效应模型合并估计并按性别、病例定义和地区进行亚组分析。

主要发现

  • SSc总体合并患病率为每10万人17.6例(95%CI 15.1, 20.5)。
  • SSc总体合并发病率为每10万人年1.4例(95%CI 1.1, 1.9)。
  • 研究报告存在显著地区差异,北美研究估计值明显高于其他地区。
  • 女性合并发病率和患病率约为男性的五倍。
  • 较新研究报告的估计值高于较早研究。

关键数值与推荐

  • SSc合并患病率17.6/10万(95%CI 15.1, 20.5),合并发病率1.4/10万人年(95%CI 1.1, 1.9)。

临床怎么用

  • 临床及流行病学解读SSc疾病负担时应考虑地区、性别和日历时期异质性,北美女性人群疾病负担估计较高。

局限性

  • 纳入研究间存在较大异质性,可能影响合并估计的解读。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: We aimed to conduct a systematic review and meta-analysis on the incidence and prevalence of SSc covering the entire literature. METHODS: This study followed the recommendations of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement of 2009. We conducted a systematic search in MEDLINE, Web of Science and Embase to identify articles reporting incidence and/or prevalence of SSc. Two authors conducted the search, reviewed articles for inclusion and extracted relevant data. We used random-effects models to estimate the pooled prevalence and incidence of SSc and performed subgroup analyses by sex, case definition and region to investigate heterogeneity. We explored the association between calendar period and reported estimates using meta-regression. RESULTS: Among 6983 unique records identified, we included 61 studies of prevalence and 39 studies of incidence in the systematic review. The overall pooled prevalence of SSc was 17.6 (95% CI 15.1, 20.5) per 100 000 and the overall pooled incidence rate of SSc was 1.4 (95% CI 1.1, 1.9) per 100 000 person-years. We observed significant regional variations in reported estimates; studies conducted in North America reported considerably higher estimates than other regions. The pooled incidence and prevalence in women were five times higher than in men. More recent studies reported higher estimates than older ones. CONCLUSION: In this comprehensive review of the incidence and prevalence of SSc across the world, there was large heterogeneity among estimates, which should be taken into consideration when interpreting the results.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Bairkdar M, Rossides M, Westerlind H, et al. Incidence and prevalence of systemic sclerosis globally: a comprehensive systematic review and meta-analysis. Rheumatology (Oxford). 2021. PMID: 33630060. doi:10.1093/rheumatology/keab190

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。